Viewing Study NCT06733051


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-01-02 @ 12:45 PM
Study NCT ID: NCT06733051
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2024-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module